IMPACT OF TUMOR EMBRYOLOGIC ORIGIN ON THE EFFICACY OF FIRST-LINE CHEMOTHERAPY IN METASTATIC COLORECTAL CANCER (mCRC) PATIENTS: A PILOT RETROSPECTIVE STUDY

被引：0
|
作者：
Valenti, Vicente [1 ]
Ramos, Javier [1 ]
Marcos, Pilar [2 ]
Perez, Cristina [1 ]
Esteller, Laura [1 ]
Sales, Ricard [1 ]
Montserrat, Angels [1 ]
Rossini, Alejandro [1 ]
Alvarez, Ana [2 ]
Germa, Josep [2 ]
机构：
[1] Xarxa Hosp Santa Tecla, Tarragona El Vendrell, Spain
[2] Capio Hosp Gen Catalunya, Sant Cugat Del Valles, Spain
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v99 / v99
页数：1
相关论文
共 50 条
  • [21] LOW USE OF BIOLOGICS IN FIRST-LINE THERAPY AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC)
    Klink, A. J.
    Nabhan, C.
    Ernst, F. R.
    Feinberg, B. A.
    VALUE IN HEALTH, 2017, 20 (05) : A129 - A129
  • [22] Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Ueno, Masashi
    Yamaguchi, Toshiharu
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (04) : 322 - 329
  • [23] Negative impact of cachexia during chemotherapy on survival as first-line chemotherapy for metastatic colorectal cancer
    Nozawa, Kazuki
    Masuishi, Toshiki
    Kumanishi, Ryosuke
    Nakazawa, Taiko
    Ogata, Takatsugu
    Matsubara, Yuki
    Kato, Kyoko
    Narita, Yukiya
    Honda, Kazunori
    Bando, Hideaki
    Kadowaki, Shigenori
    Andoh, Masashi
    Tajika, Masahiro
    Muro, Kei
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [24] Bevacizumab in combination with chemotherapy: First-line treatment of patients with metastatic colorectal cancer
    Hochster, Howard S.
    SEMINARS IN ONCOLOGY, 2006, 33 (05) : S8 - S14
  • [25] Aflibercept in combination with irinotecan, fluorouracil and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal cancer (mCRC) patients: A phase II multicentric study
    Lapeyre-Prost, A.
    Pernot, S.
    Sigrand, J.
    Mary, F.
    Le Malicot, K.
    Aparicio, T.
    Dahan, L.
    Caroli-Bosc, F-X.
    Lecomte, T.
    Doat, S. Racine
    Marthey, L.
    Desrame, J.
    Lepage, C.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2018, 29 : 160 - 160
  • [26] Prognostic Factors in First-Line Chemotherapy Treated Metastatic Gastric Cancer Patients: A Retrospective Study
    Inal, Ali
    Kaplan, M. Ali
    Kucukoner, Mehmet
    Urakci, Zuhat
    Guven, Mehmet
    Nas, Necip
    Yunce, Muharrem
    Isikdogan, Abdurrahman
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (08) : 3869 - 3872
  • [27] First-line chemotherapy with raltitrexed in metastatic colorectal cancer: An AGEO multicentre study
    Gallois, C.
    Hafliger, E.
    Auclin, E.
    Perret, A.
    Artru, P.
    Coutzac, C.
    Turpin, A.
    Pellat, A.
    Randrian, V.
    Basile, D.
    Faroux, R.
    Locher, C.
    Hautefeuille, V.
    Dubreuil, O.
    Palmieri, L-J.
    Dior, M.
    Taieb, J.
    ANNALS OF ONCOLOGY, 2020, 31 : S430 - S430
  • [28] Retrospective analysis of the efficacy of cytokine-induced killer cell immunotherapy combined with first-line chemotherapy in patients with metastatic colorectal cancer
    Pan, Qiu-Zhong
    Gu, Jia-Mei
    Zhao, Jing-Jing
    Tang, Yan
    Wang, Qi-Jing
    Zhu, Qian
    Song, Meng-Jia
    Li, Yong-Qiang
    He, Jia
    Chen, Shi-Ping
    Weng, De-Sheng
    Xia, Jian-Chuan
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (02)
  • [29] Addition of Bevacizumab to First-Line Chemotherapy for Metastatic Colorectal Cancer
    Tsutsumi, Soichi
    Fujii, Takaaki
    Yamaguchi, Satoru
    Suto, Toshinaga
    Yajima, Reina
    Morita, Hiroki
    Kato, Toshihide
    Asao, Takayuki
    Kuwano, Hiroyuki
    HEPATO-GASTROENTEROLOGY, 2014, 61 (131) : 633 - 637
  • [30] First-line bevacizumab (REV) and chemotherapy (CT) for metastatic colorectal cancer (mCRC); Results from a developing nation
    Franke, F. A.
    Azevedo, S. J.
    Gampel, O.
    Guimaraes, J. Q.
    Schaum, M. R.
    Murad, A.
    Coutinho, A. K.
    Oliveira, J. A.
    Matos Neto, J. N.
    Franca, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345